| Natalie Sridharan, | |
|
200 Lothrop St, Suite A-1017, Pittsburgh, PA 15213-2536 | |
| (412) 420-9956 | |
| Not Available |
| Full Name | Natalie Sridharan |
|---|---|
| Gender | Female |
| Speciality | Vascular Surgery |
| Experience | 12 Years |
| Location | 200 Lothrop St, Pittsburgh, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023371978 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2086S0129X | Surgery - Vascular Surgery | MT202337 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Upmc Mercy | Pittsburgh, PA | Hospital |
| Upmc Presbyterian Shadyside | Pittsburgh, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Pittsburgh Physicians | 8729990239 | 3721 |
News Archive
Aphios Corporation today announced that it has been awarded a RC-1 Challenge grant (No. 1RC1HL102822-01) from the National Heart, Lung, and Blood Institute (NHLBI), National Institute of Health's (NIH) American Recovery and Reinvestment Act (ARRA) funds to develop a generally-applicable pathogen inactivation technology for blood products.
Analog Devices, Inc., a global leader in high-performance semiconductors for signal-processing applications and long-time supplier to the medical equipment industry, today announced a collaboration with the Massachusetts Institute of Technology to research and develop technologies for next-generation patient monitoring devices.
PCI Biotech (PCIB) the Norwegian biopharmaceutical company, reported today that the first patient has been included in the phase II study of Amphinex in combination with the cytotoxic agent bleomycin in head and neck cancer patients, called the ENHANCE study. The first patient was included at the National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Germany. NCT is a joint project of the German Cancer Research Center (DKFZ), Heidelberg University Hospital, Thoraxklinik Heidelberg and Deutsche Krebshilfe (German Cancer Aid).
Children born to mothers experiencing economic hardship, who were also exposed during pregnancy to high levels of PAH (polycyclic aromatic hydrocarbons), scored significantly lower on IQ tests at age 5 compared with children born to mothers with greater economic security and less exposure to the pollutants.
› Verified 1 days ago
| Entity Name | University Of Pittsburgh Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619935004 PECOS PAC ID: 8729990239 Enrollment ID: O20040308000883 |
News Archive
Aphios Corporation today announced that it has been awarded a RC-1 Challenge grant (No. 1RC1HL102822-01) from the National Heart, Lung, and Blood Institute (NHLBI), National Institute of Health's (NIH) American Recovery and Reinvestment Act (ARRA) funds to develop a generally-applicable pathogen inactivation technology for blood products.
Analog Devices, Inc., a global leader in high-performance semiconductors for signal-processing applications and long-time supplier to the medical equipment industry, today announced a collaboration with the Massachusetts Institute of Technology to research and develop technologies for next-generation patient monitoring devices.
PCI Biotech (PCIB) the Norwegian biopharmaceutical company, reported today that the first patient has been included in the phase II study of Amphinex in combination with the cytotoxic agent bleomycin in head and neck cancer patients, called the ENHANCE study. The first patient was included at the National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Germany. NCT is a joint project of the German Cancer Research Center (DKFZ), Heidelberg University Hospital, Thoraxklinik Heidelberg and Deutsche Krebshilfe (German Cancer Aid).
Children born to mothers experiencing economic hardship, who were also exposed during pregnancy to high levels of PAH (polycyclic aromatic hydrocarbons), scored significantly lower on IQ tests at age 5 compared with children born to mothers with greater economic security and less exposure to the pollutants.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Natalie Sridharan, 200 Lothrop St, Suite A-1017, Pittsburgh, PA 15213-2536 Ph: () - | Natalie Sridharan, 200 Lothrop St, Suite A-1017, Pittsburgh, PA 15213-2536 Ph: (412) 420-9956 |
News Archive
Aphios Corporation today announced that it has been awarded a RC-1 Challenge grant (No. 1RC1HL102822-01) from the National Heart, Lung, and Blood Institute (NHLBI), National Institute of Health's (NIH) American Recovery and Reinvestment Act (ARRA) funds to develop a generally-applicable pathogen inactivation technology for blood products.
Analog Devices, Inc., a global leader in high-performance semiconductors for signal-processing applications and long-time supplier to the medical equipment industry, today announced a collaboration with the Massachusetts Institute of Technology to research and develop technologies for next-generation patient monitoring devices.
PCI Biotech (PCIB) the Norwegian biopharmaceutical company, reported today that the first patient has been included in the phase II study of Amphinex in combination with the cytotoxic agent bleomycin in head and neck cancer patients, called the ENHANCE study. The first patient was included at the National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Germany. NCT is a joint project of the German Cancer Research Center (DKFZ), Heidelberg University Hospital, Thoraxklinik Heidelberg and Deutsche Krebshilfe (German Cancer Aid).
Children born to mothers experiencing economic hardship, who were also exposed during pregnancy to high levels of PAH (polycyclic aromatic hydrocarbons), scored significantly lower on IQ tests at age 5 compared with children born to mothers with greater economic security and less exposure to the pollutants.
› Verified 1 days ago
Dr. Jose Manuel Prince, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 6340 Morrowfield Ave, Pittsburgh, PA 15217 Phone: 412-421-3377 | |
Mr. Vei Shaun Siow, Surgery Medicare: Medicare Enrolled Practice Location: 5140 Liberty Ave Ste 200, Pittsburgh, PA 15224 Phone: 412-359-6137 Fax: 412-688-7799 | |
Mr. Derek Ray Serna-gallegos, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 5200 Centre Ave Ste 715, Pittsburgh, PA 15232 Phone: 299-441-2623 | |
Othman Mohamed-asem Abdul-malak, Surgery Medicare: Medicare Enrolled Practice Location: 200 Lothrop St, F600 Presbyterian Hospital, Pittsburgh, PA 15213 Phone: 412-647-2345 | |
Allan S Philp Jr., MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 320 E North Ave Fl 3, Pittsburgh, PA 15212 Phone: 412-359-3115 Fax: 412-359-3165 | |
Dr. Jeffrey Allen Perri, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1050 Bower Hill Rd, Suite 302, Pittsburgh, PA 15243 Phone: 412-942-5660 Fax: 412-942-5687 | |
Bart A. Chess, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 320 E North Ave, Pittsburgh, PA 15212 Phone: 412-359-8820 Fax: 412-359-8222 |